BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 50169452 CC(C)(C)OC(=O)N1CCCCC1CNc1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C32H37F6N7O2/c1-30(2,3)47-29(46)45-16-5-4-7-22(45)19-40-28-42-25-14-18-44(27-24(32(36,37)38)8-6-15-39-27)17-13-23(25)26(43-28)41-21-11-9-20(10-12-21)31(33,34)35/h6,8-12,15,22H,4-5,7,13-14,16-19H2,1-3H3,(H2,40,41,42,43) QBAAPNYTIXKOSR-UHFFFAOYSA-N 50332867 tert-butyl 2-((4-(4-(trifluoromethyl)phenylamino)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-2-ylamino)methyl)piperidine-1-carboxylate::CHEMBL1630631 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 250 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332867 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332867&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53320485 125082969 CHEMBL1630631 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169453 FC(F)(F)c1ccc(Nc2nc(nc3CCN(CCc23)c2ncccc2C(F)(F)F)N2CCOCC2)cc1 InChI=1S/C25H24F6N6O/c26-24(27,28)16-3-5-17(6-4-16)33-21-18-7-10-36(22-19(25(29,30)31)2-1-9-32-22)11-8-20(18)34-23(35-21)37-12-14-38-15-13-37/h1-6,9H,7-8,10-15H2,(H,33,34,35) LKHROBPDTDXUDN-UHFFFAOYSA-N 50331116 2-morpholino-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1289607::US9422293, 40 and 40A::US9738649, Example 40A Transient receptor potential cation channel subfamily V member 1 Homo sapiens 6 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50331116&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 24783403 123110231 CHEMBL1289607 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169454 CN(C)[C@H]1CCN(C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F |r| InChI=1S/C27H29F6N7/c1-38(2)19-9-13-40(16-19)25-36-22-11-15-39(24-21(27(31,32)33)4-3-12-34-24)14-10-20(22)23(37-25)35-18-7-5-17(6-8-18)26(28,29)30/h3-8,12,19H,9-11,13-16H2,1-2H3,(H,35,36,37) PKILCYFBQFTXGK-UHFFFAOYSA-N 50332860 (S)-2-(3-(dimethylamino)pyrrolidin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630624 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 185 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332860 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332860&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53325771 125082962 CHEMBL1630624 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169455 CN(C)[C@@H]1CCN(C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F |r| InChI=1S/C27H29F6N7/c1-38(2)19-9-13-40(16-19)25-36-22-11-15-39(24-21(27(31,32)33)4-3-12-34-24)14-10-20(22)23(37-25)35-18-7-5-17(6-8-18)26(28,29)30/h3-8,12,19H,9-11,13-16H2,1-2H3,(H,35,36,37) PKILCYFBQFTXGK-UHFFFAOYSA-N 50332859 (R)-2-(3-(dimethylamino)pyrrolidin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630623 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 243 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332859 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332859&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53325663 125082961 CHEMBL1630623 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169456 FC(F)(F)c1ccc(Nc2nc(NC3CCCNC3)nc3CCN(CCc23)c2ncccc2C(F)(F)F)cc1 InChI=1S/C26H27F6N7/c27-25(28,29)16-5-7-17(8-6-16)35-22-19-9-13-39(23-20(26(30,31)32)4-2-12-34-23)14-10-21(19)37-24(38-22)36-18-3-1-11-33-15-18/h2,4-8,12,18,33H,1,3,9-11,13-15H2,(H2,35,36,37,38) VZAFKJMMFIFKPS-UHFFFAOYSA-N 50332862 N2-(piperidin-3-yl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630626 Transient receptor potential cation channel subfamily V member 1 Homo sapiens >5000 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332862 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332862&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53320484 125082964 CHEMBL1630626 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169457 CC(C)(C)OC(=O)N1CCCC(C1)Nc1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C31H35F6N7O2/c1-29(2,3)46-28(45)44-15-5-6-21(18-44)40-27-41-24-13-17-43(26-23(31(35,36)37)7-4-14-38-26)16-12-22(24)25(42-27)39-20-10-8-19(9-11-20)30(32,33)34/h4,7-11,14,21H,5-6,12-13,15-18H2,1-3H3,(H2,39,40,41,42) CJEGOASZCHMBGO-UHFFFAOYSA-N 50332861 tert-butyl 3-(4-(4-(trifluoromethyl)phenylamino)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-2-ylamino)piperidine-1-carboxylate::CHEMBL1630625 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 140 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332861 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332861&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53319165 125082963 CHEMBL1630625 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169458 CN(C1CCCN(C1)C(=O)OC(C)(C)C)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C32H37F6N7O2/c1-30(2,3)47-29(46)45-16-6-7-22(19-45)43(4)28-41-25-14-18-44(27-24(32(36,37)38)8-5-15-39-27)17-13-23(25)26(42-28)40-21-11-9-20(10-12-21)31(33,34)35/h5,8-12,15,22H,6-7,13-14,16-19H2,1-4H3,(H,40,41,42) UYKWYCSLAOFZHJ-UHFFFAOYSA-N 50332864 tert-butyl 3-(methyl(4-(4-(trifluoromethyl)phenylamino)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-2-yl)amino)piperidine-1-carboxylate::CHEMBL1630628 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 53 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332864 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332864&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53321783 125082966 CHEMBL1630628 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169459 CN1CCCC(C1)Nc1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C27H29F6N7/c1-39-13-3-4-19(16-39)36-25-37-22-11-15-40(24-21(27(31,32)33)5-2-12-34-24)14-10-20(22)23(38-25)35-18-8-6-17(7-9-18)26(28,29)30/h2,5-9,12,19H,3-4,10-11,13-16H2,1H3,(H2,35,36,37,38) UKGUYMZTTOHLED-UHFFFAOYSA-N 50332863 N2-(1-methylpiperidin-3-yl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630627 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 3080 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332863 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332863&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53325772 125082965 CHEMBL1630627 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169460 CC(C)CN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C29H33F6N7/c1-19(2)18-40-14-16-42(17-15-40)27-38-24-10-13-41(26-23(29(33,34)35)4-3-11-36-26)12-9-22(24)25(39-27)37-21-7-5-20(6-8-21)28(30,31)32/h3-8,11,19H,9-10,12-18H2,1-2H3,(H,37,38,39) IBGHJRNYLZKHRY-UHFFFAOYSA-N 50332846 2-(4-isobutylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630299 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 67 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332846 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332846&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 49870854 125082948 CHEMBL1630299 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169461 CN(C1CCCN(C)C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C28H31F6N7/c1-39-14-4-5-20(17-39)40(2)26-37-23-12-16-41(25-22(28(32,33)34)6-3-13-35-25)15-11-21(23)24(38-26)36-19-9-7-18(8-10-19)27(29,30)31/h3,6-10,13,20H,4-5,11-12,14-17H2,1-2H3,(H,36,37,38) GBYAZONQWPEDEC-UHFFFAOYSA-N 50332866 N2-methyl-N2-(1-methylpiperidin-3-yl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630630 Transient receptor potential cation channel subfamily V member 1 Homo sapiens >5000 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332866 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332866&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53320373 125082968 CHEMBL1630630 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169462 CN(C1CCCNC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C27H29F6N7/c1-39(19-4-2-12-34-16-19)25-37-22-11-15-40(24-21(27(31,32)33)5-3-13-35-24)14-10-20(22)23(38-25)36-18-8-6-17(7-9-18)26(28,29)30/h3,5-9,13,19,34H,2,4,10-12,14-16H2,1H3,(H,36,37,38) UNQRZPZKFDHQJJ-UHFFFAOYSA-N 50332865 N2-methyl-N2-(piperidin-3-yl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630629 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 3600 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332865 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332865&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53316531 125082967 CHEMBL1630629 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169463 CNC1CCN(C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C26H27F6N7/c1-33-18-8-12-39(15-18)24-36-21-10-14-38(23-20(26(30,31)32)3-2-11-34-23)13-9-19(21)22(37-24)35-17-6-4-16(5-7-17)25(27,28)29/h2-7,11,18,33H,8-10,12-15H2,1H3,(H,35,36,37) VXNXKOQHRMWNCX-UHFFFAOYSA-N 50332858 2-(3-(methylamino)pyrrolidin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1629722 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 2790 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332858 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332858&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53325956 125082960 CHEMBL1629722 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169464 FC(F)(F)c1ccc(Nc2nc(nc3CCN(CCc23)c2ncccc2C(F)(F)F)N2CCN(CC2)C2CCC2)cc1 InChI=1S/C29H31F6N7/c30-28(31,32)19-6-8-20(9-7-19)37-25-22-10-13-41(26-23(29(33,34)35)5-2-12-36-26)14-11-24(22)38-27(39-25)42-17-15-40(16-18-42)21-3-1-4-21/h2,5-9,12,21H,1,3-4,10-11,13-18H2,(H,37,38,39) AZRVHUILULJHOJ-UHFFFAOYSA-N 50332849 2-(4-cyclobutylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630302 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 24 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332849 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332849&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53325658 125082951 CHEMBL1630302 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169465 FC(F)(F)c1ccc(Nc2nc(nc3CCN(CCc23)c2ncccc2C(F)(F)F)N2CCN(CC2)C2CC2)cc1 InChI=1S/C28H29F6N7/c29-27(30,31)18-3-5-19(6-4-18)36-24-21-9-12-40(25-22(28(32,33)34)2-1-11-35-25)13-10-23(21)37-26(38-24)41-16-14-39(15-17-41)20-7-8-20/h1-6,11,20H,7-10,12-17H2,(H,36,37,38) VARATGTYNUKROK-UHFFFAOYSA-N 50332848 2-(4-cyclopropylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630301 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 11 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332848 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332848&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53321847 125082950 CHEMBL1630301 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169466 COCCN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C28H31F6N7O/c1-42-18-17-39-13-15-41(16-14-39)26-37-23-9-12-40(25-22(28(32,33)34)3-2-10-35-25)11-8-21(23)24(38-26)36-20-6-4-19(5-7-20)27(29,30)31/h2-7,10H,8-9,11-18H2,1H3,(H,36,37,38) NPICNXRKKUTWHW-UHFFFAOYSA-N 50332851 2-(4-(2-methoxyethyl)piperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630304 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 65 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332851 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332851&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53316590 125082953 CHEMBL1630304 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169467 FC(F)(F)c1ccc(Nc2nc(nc3CCN(CCc23)c2ncccc2C(F)(F)F)N2CCN(CC2)C2CCCC2)cc1 InChI=1S/C30H33F6N7/c31-29(32,33)20-7-9-21(10-8-20)38-26-23-11-14-42(27-24(30(34,35)36)6-3-13-37-27)15-12-25(23)39-28(40-26)43-18-16-41(17-19-43)22-4-1-2-5-22/h3,6-10,13,22H,1-2,4-5,11-12,14-19H2,(H,38,39,40) AFFXSFAWMDBWFI-UHFFFAOYSA-N 50332850 2-(4-cyclopentylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630303 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 15 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332850 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332850&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53318736 125082952 CHEMBL1630303 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169468 FC(F)(F)c1ccc(Nc2nc(nc3CCN(CCc23)c2ncccc2C(F)(F)F)N2CCNCC2)cc1 InChI=1S/C25H25F6N7/c26-24(27,28)16-3-5-17(6-4-16)34-21-18-7-12-37(22-19(25(29,30)31)2-1-9-33-22)13-8-20(18)35-23(36-21)38-14-10-32-11-15-38/h1-6,9,32H,7-8,10-15H2,(H,34,35,36) DHTPCPXEBHJGGR-UHFFFAOYSA-N 50331119 2-(piperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1289932::US9422293, 99B::US9738649, Example 99B Transient receptor potential cation channel subfamily V member 1 Homo sapiens 3350 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50331119&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 52944807 123110234 CHEMBL1289932 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169469 CN(C)CCN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C29H34F6N8/c1-40(2)14-15-41-16-18-43(19-17-41)27-38-24-10-13-42(26-23(29(33,34)35)4-3-11-36-26)12-9-22(24)25(39-27)37-21-7-5-20(6-8-21)28(30,31)32/h3-8,11H,9-10,12-19H2,1-2H3,(H,37,38,39) NRZHWWVFFNPRMV-UHFFFAOYSA-N 50332853 2-(4-(2-(dimethylamino)ethyl)piperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630617 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 2000 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332853 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332853&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53323109 125082955 CHEMBL1630617 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169470 CCN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C27H29F6N7/c1-2-38-14-16-40(17-15-38)25-36-22-10-13-39(24-21(27(31,32)33)4-3-11-34-24)12-9-20(22)23(37-25)35-19-7-5-18(6-8-19)26(28,29)30/h3-8,11H,2,9-10,12-17H2,1H3,(H,35,36,37) HGCCDPILHOOZPK-UHFFFAOYSA-N 50332844 2-(4-ethylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630297 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 132 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332844 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332844&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53319221 125082946 CHEMBL1630297 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169471 CN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C26H27F6N7/c1-37-13-15-39(16-14-37)24-35-21-9-12-38(23-20(26(30,31)32)3-2-10-33-23)11-8-19(21)22(36-24)34-18-6-4-17(5-7-18)25(27,28)29/h2-7,10H,8-9,11-16H2,1H3,(H,34,35,36) FXFWLGLXQDHULE-UHFFFAOYSA-N 50332843 2-(4-methylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630296::US9422293, 92B::US9738649, Example 92B Transient receptor potential cation channel subfamily V member 1 Homo sapiens 367 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332843 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332843&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53316588 125082945 CHEMBL1630296 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169472 CN(C)CCN(C)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C26H29F6N7/c1-37(2)15-16-38(3)24-35-21-11-14-39(23-20(26(30,31)32)5-4-12-33-23)13-10-19(21)22(36-24)34-18-8-6-17(7-9-18)25(27,28)29/h4-9,12H,10-11,13-16H2,1-3H3,(H,34,35,36) LXGUQYLBTQNGHK-UHFFFAOYSA-N 50332854 N2-(2-(dimethylamino)ethyl)-N2-methyl-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630619::US9422293, 225::US9738649, Example 219 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 2667 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332854 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332854&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53321780 125082956 CHEMBL1630619 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169474 FC(F)(F)c1ccc(Nc2nc(NCc3ccccn3)nc3CCN(CCc23)c2ncccc2C(F)(F)F)cc1 InChI=1S/C27H23F6N7/c28-26(29,30)17-6-8-18(9-7-17)37-23-20-10-14-40(24-21(27(31,32)33)5-3-13-35-24)15-11-22(20)38-25(39-23)36-16-19-4-1-2-12-34-19/h1-9,12-13H,10-11,14-16H2,(H2,36,37,38,39) HULIPYRTZHBHFC-UHFFFAOYSA-N 50332871 N2-(pyridin-2-ylmethyl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1631259 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 476 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332871 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332871&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53326824 125082973 CHEMBL1631259 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169475 CC(C)CN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C29H33F6N7/c1-19(2)18-40-14-16-42(17-15-40)27-38-24-10-13-41(26-23(29(33,34)35)4-3-11-36-26)12-9-22(24)25(39-27)37-21-7-5-20(6-8-21)28(30,31)32/h3-8,11,19H,9-10,12-18H2,1-2H3,(H,37,38,39) IBGHJRNYLZKHRY-UHFFFAOYSA-N 50332846 2-(4-isobutylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630299 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 11 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332846 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332846&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 49870854 125082948 CHEMBL1630299 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169480 OCCN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C27H29F6N7O/c28-26(29,30)18-3-5-19(6-4-18)35-23-20-7-10-39(24-21(27(31,32)33)2-1-9-34-24)11-8-22(20)36-25(37-23)40-14-12-38(13-15-40)16-17-41/h1-6,9,41H,7-8,10-17H2,(H,35,36,37) DGBYTQSMHNWONG-UHFFFAOYSA-N 50332852 2-(4-(4-(4-(trifluoromethyl)phenylamino)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-2-yl)piperazin-1-yl)ethanol::CHEMBL1630618 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 498 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332852 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332852&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53321779 125082954 CHEMBL1630618 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169481 CC(C)N1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C28H31F6N7/c1-18(2)39-14-16-41(17-15-39)26-37-23-10-13-40(25-22(28(32,33)34)4-3-11-35-25)12-9-21(23)24(38-26)36-20-7-5-19(6-8-20)27(29,30)31/h3-8,11,18H,9-10,12-17H2,1-2H3,(H,36,37,38) BYFVNPPBJXPELG-UHFFFAOYSA-N 50332845 2-(4-isopropylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630298::US9422293, 60B::US9738649, Example 60B Transient receptor potential cation channel subfamily V member 1 Homo sapiens 91 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332845 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332845&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53323161 125082947 CHEMBL1630298 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169484 NC1CCN(C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C25H25F6N7/c26-24(27,28)15-3-5-17(6-4-15)34-21-18-8-12-37(22-19(25(29,30)31)2-1-10-33-22)13-9-20(18)35-23(36-21)38-11-7-16(32)14-38/h1-6,10,16H,7-9,11-14,32H2,(H,34,35,36) MQZNVVGXQUUFML-UHFFFAOYSA-N 50332856 2-(3-aminopyrrolidin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630621 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 3700 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332856 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332856&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53321781 125082958 CHEMBL1630621 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169489 CC(=O)NC1CCN(C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C27H27F6N7O/c1-16(41)35-19-8-12-40(15-19)25-37-22-10-14-39(24-21(27(31,32)33)3-2-11-34-24)13-9-20(22)23(38-25)36-18-6-4-17(5-7-18)26(28,29)30/h2-7,11,19H,8-10,12-15H2,1H3,(H,35,41)(H,36,37,38) IIVNLXXBFIWTOK-UHFFFAOYSA-N 50332855 N-(1-(4-(4-(trifluoromethyl)phenylamino)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-2-yl)pyrrolidin-3-yl)acetamide::CHEMBL1630620 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 150 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332855 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332855&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53325770 125082957 CHEMBL1630620 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169491 CCC(CC)N1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C30H35F6N7/c1-3-22(4-2)41-16-18-43(19-17-41)28-39-25-12-15-42(27-24(30(34,35)36)6-5-13-37-27)14-11-23(25)26(40-28)38-21-9-7-20(8-10-21)29(31,32)33/h5-10,13,22H,3-4,11-12,14-19H2,1-2H3,(H,38,39,40) ICSWMFYHORSGPO-UHFFFAOYSA-N 50332847 2-(4-(pentan-3-yl)piperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630300 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 41 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332847 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332847&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53316589 125082949 CHEMBL1630300 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169492 CC(C)CN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C29H33F6N7/c1-19(2)18-40-14-16-42(17-15-40)27-38-24-10-13-41(26-23(29(33,34)35)4-3-11-36-26)12-9-22(24)25(39-27)37-21-7-5-20(6-8-21)28(30,31)32/h3-8,11,19H,9-10,12-18H2,1-2H3,(H,37,38,39) IBGHJRNYLZKHRY-UHFFFAOYSA-N 50332846 2-(4-isobutylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630299 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 330 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332846 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332846&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 49870854 125082948 CHEMBL1630299 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50169494 CN1CCCCC1CNc1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C28H31F6N7/c1-40-14-3-2-5-20(40)17-36-26-38-23-12-16-41(25-22(28(32,33)34)6-4-13-35-25)15-11-21(23)24(39-26)37-19-9-7-18(8-10-19)27(29,30)31/h4,6-10,13,20H,2-3,5,11-12,14-17H2,1H3,(H2,36,37,38,39) JZNBBUHXLHNYJX-UHFFFAOYSA-N 50332869 N2-((1-methylpiperidin-2-yl)methyl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630633 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 1756 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332869 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332869&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53317849 125082971 CHEMBL1630633 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169497 CN(C1CCN(C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F)C(C)=O InChI=1S/C28H29F6N7O/c1-17(42)39(2)20-9-13-41(16-20)26-37-23-11-15-40(25-22(28(32,33)34)4-3-12-35-25)14-10-21(23)24(38-26)36-19-7-5-18(6-8-19)27(29,30)31/h3-8,12,20H,9-11,13-16H2,1-2H3,(H,36,37,38) AWFVISZDKAPGAO-UHFFFAOYSA-N 50332857 N-methyl-N-(1-(4-(4-(trifluoromethyl)phenylamino)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-2-yl)pyrrolidin-3-yl)acetamide::CHEMBL1630622 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 62 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332857 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332857&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53321782 125082959 CHEMBL1630622 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169501 FC(F)(F)c1ccc(Nc2nc(NCC3CCCCN3)nc3CCN(CCc23)c2ncccc2C(F)(F)F)cc1 InChI=1S/C27H29F6N7/c28-26(29,30)17-6-8-18(9-7-17)37-23-20-10-14-40(24-21(27(31,32)33)5-3-13-35-24)15-11-22(20)38-25(39-23)36-16-19-4-1-2-12-34-19/h3,5-9,13,19,34H,1-2,4,10-12,14-16H2,(H2,36,37,38,39) VZEJNYBCKKADCX-UHFFFAOYSA-N 50332868 N2-(piperidin-2-ylmethyl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630632 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 100 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332868 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332868&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53324459 125082970 CHEMBL1630632 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169502 CN(CC1CCCCN1C)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C29H33F6N7/c1-40-15-4-3-6-21(40)18-41(2)27-38-24-13-17-42(26-23(29(33,34)35)7-5-14-36-26)16-12-22(24)25(39-27)37-20-10-8-19(9-11-20)28(30,31)32/h5,7-11,14,21H,3-4,6,12-13,15-18H2,1-2H3,(H,37,38,39) JYLAXWCUPMUZAQ-UHFFFAOYSA-N 50332870 N2-methyl-N2-((1-methylpiperidin-2-yl)methyl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1631258 Transient receptor potential cation channel subfamily V member 1 Homo sapiens 3330 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332870 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6342&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332870&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53319909 125082972 CHEMBL1631258 1 MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFEAVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEIARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKTKGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTADNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEILSVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVASMVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIEDGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSSRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK 9P6B,8GFA,8GF9,8GF8,8X94,8JQR Transient receptor potential cation channel subfamily V member 1 TRPV1_HUMAN Q8NER1 A2RUA9 Q3LU47 Q9H0G9 Q9H303 Q9H304 Q9NQ74 Q9NY22 50169506 CC(C)CN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C29H33F6N7/c1-19(2)18-40-14-16-42(17-15-40)27-38-24-10-13-41(26-23(29(33,34)35)4-3-11-36-26)12-9-22(24)25(39-27)37-21-7-5-20(6-8-21)28(30,31)32/h3-8,11,19H,9-10,12-18H2,1-2H3,(H,37,38,39) IBGHJRNYLZKHRY-UHFFFAOYSA-N 50332846 2-(4-isobutylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630299 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 89 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332846 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332846&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 49870854 125082948 CHEMBL1630299 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613182 FC(F)(F)c1ccc(Nc2nc(nc3CCN(CCc23)c2ncccc2C(F)(F)F)N2CCNCC2)cc1 InChI=1S/C25H25F6N7/c26-24(27,28)16-3-5-17(6-4-16)34-21-18-7-12-37(22-19(25(29,30)31)2-1-9-33-22)13-8-20(18)35-23(36-21)38-14-10-32-11-15-38/h1-6,9,32H,7-8,10-15H2,(H,34,35,36) DHTPCPXEBHJGGR-UHFFFAOYSA-N 50331119 2-(piperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1289932::US9422293, 99B::US9738649, Example 99B Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus >5000 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50331119&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 52944807 123110234 CHEMBL1289932 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613183 CN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C26H27F6N7/c1-37-13-15-39(16-14-37)24-35-21-9-12-38(23-20(26(30,31)32)3-2-10-33-23)11-8-19(21)22(36-24)34-18-6-4-17(5-7-18)25(27,28)29/h2-7,10H,8-9,11-16H2,1H3,(H,34,35,36) FXFWLGLXQDHULE-UHFFFAOYSA-N 50332843 2-(4-methylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630296::US9422293, 92B::US9738649, Example 92B Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 506 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332843 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332843&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53316588 125082945 CHEMBL1630296 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613184 CCN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C27H29F6N7/c1-2-38-14-16-40(17-15-38)25-36-22-10-13-39(24-21(27(31,32)33)4-3-11-34-24)12-9-20(22)23(37-25)35-19-7-5-18(6-8-19)26(28,29)30/h3-8,11H,2,9-10,12-17H2,1H3,(H,35,36,37) HGCCDPILHOOZPK-UHFFFAOYSA-N 50332844 2-(4-ethylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630297 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 506 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332844 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332844&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53319221 125082946 CHEMBL1630297 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613185 CC(C)N1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C28H31F6N7/c1-18(2)39-14-16-41(17-15-39)26-37-23-10-13-40(25-22(28(32,33)34)4-3-11-35-25)12-9-21(23)24(38-26)36-20-7-5-19(6-8-20)27(29,30)31/h3-8,11,18H,9-10,12-17H2,1-2H3,(H,36,37,38) BYFVNPPBJXPELG-UHFFFAOYSA-N 50332845 2-(4-isopropylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630298::US9422293, 60B::US9738649, Example 60B Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 386 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332845 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332845&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53323161 125082947 CHEMBL1630298 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613187 CCC(CC)N1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C30H35F6N7/c1-3-22(4-2)41-16-18-43(19-17-41)28-39-25-12-15-42(27-24(30(34,35)36)6-5-13-37-27)14-11-23(25)26(40-28)38-21-9-7-20(8-10-21)29(31,32)33/h5-10,13,22H,3-4,11-12,14-19H2,1-2H3,(H,38,39,40) ICSWMFYHORSGPO-UHFFFAOYSA-N 50332847 2-(4-(pentan-3-yl)piperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630300 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 185 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332847 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332847&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53316589 125082949 CHEMBL1630300 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613188 FC(F)(F)c1ccc(Nc2nc(nc3CCN(CCc23)c2ncccc2C(F)(F)F)N2CCN(CC2)C2CC2)cc1 InChI=1S/C28H29F6N7/c29-27(30,31)18-3-5-19(6-4-18)36-24-21-9-12-40(25-22(28(32,33)34)2-1-11-35-25)13-10-23(21)37-26(38-24)41-16-14-39(15-17-41)20-7-8-20/h1-6,11,20H,7-10,12-17H2,(H,36,37,38) VARATGTYNUKROK-UHFFFAOYSA-N 50332848 2-(4-cyclopropylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630301 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 45 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332848 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332848&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53321847 125082950 CHEMBL1630301 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613189 FC(F)(F)c1ccc(Nc2nc(nc3CCN(CCc23)c2ncccc2C(F)(F)F)N2CCN(CC2)C2CCC2)cc1 InChI=1S/C29H31F6N7/c30-28(31,32)19-6-8-20(9-7-19)37-25-22-10-13-41(26-23(29(33,34)35)5-2-12-36-26)14-11-24(22)38-27(39-25)42-17-15-40(16-18-42)21-3-1-4-21/h2,5-9,12,21H,1,3-4,10-11,13-18H2,(H,37,38,39) AZRVHUILULJHOJ-UHFFFAOYSA-N 50332849 2-(4-cyclobutylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630302 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 161 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332849 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332849&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53325658 125082951 CHEMBL1630302 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613190 FC(F)(F)c1ccc(Nc2nc(nc3CCN(CCc23)c2ncccc2C(F)(F)F)N2CCN(CC2)C2CCCC2)cc1 InChI=1S/C30H33F6N7/c31-29(32,33)20-7-9-21(10-8-20)38-26-23-11-14-42(27-24(30(34,35)36)6-3-13-37-27)15-12-25(23)39-28(40-26)43-18-16-41(17-19-43)22-4-1-2-5-22/h3,6-10,13,22H,1-2,4-5,11-12,14-19H2,(H,38,39,40) AFFXSFAWMDBWFI-UHFFFAOYSA-N 50332850 2-(4-cyclopentylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630303 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 123 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332850 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332850&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53318736 125082952 CHEMBL1630303 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613191 COCCN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C28H31F6N7O/c1-42-18-17-39-13-15-41(16-14-39)26-37-23-9-12-40(25-22(28(32,33)34)3-2-10-35-25)11-8-21(23)24(38-26)36-20-6-4-19(5-7-20)27(29,30)31/h2-7,10H,8-9,11-18H2,1H3,(H,36,37,38) NPICNXRKKUTWHW-UHFFFAOYSA-N 50332851 2-(4-(2-methoxyethyl)piperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630304 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 207 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332851 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332851&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53316590 125082953 CHEMBL1630304 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613192 OCCN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C27H29F6N7O/c28-26(29,30)18-3-5-19(6-4-18)35-23-20-7-10-39(24-21(27(31,32)33)2-1-9-34-24)11-8-22(20)36-25(37-23)40-14-12-38(13-15-40)16-17-41/h1-6,9,41H,7-8,10-17H2,(H,35,36,37) DGBYTQSMHNWONG-UHFFFAOYSA-N 50332852 2-(4-(4-(4-(trifluoromethyl)phenylamino)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-2-yl)piperazin-1-yl)ethanol::CHEMBL1630618 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 1161 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332852 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332852&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53321779 125082954 CHEMBL1630618 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613193 CN(C)CCN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C29H34F6N8/c1-40(2)14-15-41-16-18-43(19-17-41)27-38-24-10-13-42(26-23(29(33,34)35)4-3-11-36-26)12-9-22(24)25(39-27)37-21-7-5-20(6-8-21)28(30,31)32/h3-8,11H,9-10,12-19H2,1-2H3,(H,37,38,39) NRZHWWVFFNPRMV-UHFFFAOYSA-N 50332853 2-(4-(2-(dimethylamino)ethyl)piperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630617 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 2600 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332853 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332853&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53323109 125082955 CHEMBL1630617 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613194 CN(C)CCN(C)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C26H29F6N7/c1-37(2)15-16-38(3)24-35-21-11-14-39(23-20(26(30,31)32)5-4-12-33-23)13-10-19(21)22(36-24)34-18-8-6-17(7-9-18)25(27,28)29/h4-9,12H,10-11,13-16H2,1-3H3,(H,34,35,36) LXGUQYLBTQNGHK-UHFFFAOYSA-N 50332854 N2-(2-(dimethylamino)ethyl)-N2-methyl-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630619::US9422293, 225::US9738649, Example 219 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 4449 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332854 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332854&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53321780 125082956 CHEMBL1630619 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613195 CC(=O)NC1CCN(C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C27H27F6N7O/c1-16(41)35-19-8-12-40(15-19)25-37-22-10-14-39(24-21(27(31,32)33)3-2-11-34-24)13-9-20(22)23(38-25)36-18-6-4-17(5-7-18)26(28,29)30/h2-7,11,19H,8-10,12-15H2,1H3,(H,35,41)(H,36,37,38) IIVNLXXBFIWTOK-UHFFFAOYSA-N 50332855 N-(1-(4-(4-(trifluoromethyl)phenylamino)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-2-yl)pyrrolidin-3-yl)acetamide::CHEMBL1630620 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 410 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332855 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332855&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53325770 125082957 CHEMBL1630620 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613196 NC1CCN(C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C25H25F6N7/c26-24(27,28)15-3-5-17(6-4-15)34-21-18-8-12-37(22-19(25(29,30)31)2-1-10-33-22)13-9-20(18)35-23(36-21)38-11-7-16(32)14-38/h1-6,10,16H,7-9,11-14,32H2,(H,34,35,36) MQZNVVGXQUUFML-UHFFFAOYSA-N 50332856 2-(3-aminopyrrolidin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630621 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus >5000 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332856 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332856&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53321781 125082958 CHEMBL1630621 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613197 CN(C1CCN(C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F)C(C)=O InChI=1S/C28H29F6N7O/c1-17(42)39(2)20-9-13-41(16-20)26-37-23-11-15-40(25-22(28(32,33)34)4-3-12-35-25)14-10-21(23)24(38-26)36-19-7-5-18(6-8-19)27(29,30)31/h3-8,12,20H,9-11,13-16H2,1-2H3,(H,36,37,38) AWFVISZDKAPGAO-UHFFFAOYSA-N 50332857 N-methyl-N-(1-(4-(4-(trifluoromethyl)phenylamino)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-2-yl)pyrrolidin-3-yl)acetamide::CHEMBL1630622 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 460 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332857 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332857&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53321782 125082959 CHEMBL1630622 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613198 CNC1CCN(C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C26H27F6N7/c1-33-18-8-12-39(15-18)24-36-21-10-14-38(23-20(26(30,31)32)3-2-11-34-23)13-9-19(21)22(37-24)35-17-6-4-16(5-7-17)25(27,28)29/h2-7,11,18,33H,8-10,12-15H2,1H3,(H,35,36,37) VXNXKOQHRMWNCX-UHFFFAOYSA-N 50332858 2-(3-(methylamino)pyrrolidin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1629722 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus >5000 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332858 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332858&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53325956 125082960 CHEMBL1629722 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613199 CN(C)[C@@H]1CCN(C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F |r| InChI=1S/C27H29F6N7/c1-38(2)19-9-13-40(16-19)25-36-22-11-15-39(24-21(27(31,32)33)4-3-12-34-24)14-10-20(22)23(37-25)35-18-7-5-17(6-8-18)26(28,29)30/h3-8,12,19H,9-11,13-16H2,1-2H3,(H,35,36,37) PKILCYFBQFTXGK-UHFFFAOYSA-N 50332859 (R)-2-(3-(dimethylamino)pyrrolidin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630623 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 1042 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332859 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332859&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53325663 125082961 CHEMBL1630623 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613200 CN(C)[C@H]1CCN(C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F |r| InChI=1S/C27H29F6N7/c1-38(2)19-9-13-40(16-19)25-36-22-11-15-39(24-21(27(31,32)33)4-3-12-34-24)14-10-20(22)23(37-25)35-18-7-5-17(6-8-18)26(28,29)30/h3-8,12,19H,9-11,13-16H2,1-2H3,(H,35,36,37) PKILCYFBQFTXGK-UHFFFAOYSA-N 50332860 (S)-2-(3-(dimethylamino)pyrrolidin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630624 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 586 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332860 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332860&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53325771 125082962 CHEMBL1630624 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613201 CC(C)(C)OC(=O)N1CCCC(C1)Nc1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C31H35F6N7O2/c1-29(2,3)46-28(45)44-15-5-6-21(18-44)40-27-41-24-13-17-43(26-23(31(35,36)37)7-4-14-38-26)16-12-22(24)25(42-27)39-20-10-8-19(9-11-20)30(32,33)34/h4,7-11,14,21H,5-6,12-13,15-18H2,1-3H3,(H2,39,40,41,42) CJEGOASZCHMBGO-UHFFFAOYSA-N 50332861 tert-butyl 3-(4-(4-(trifluoromethyl)phenylamino)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-2-ylamino)piperidine-1-carboxylate::CHEMBL1630625 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 239 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332861 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332861&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53319165 125082963 CHEMBL1630625 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613202 FC(F)(F)c1ccc(Nc2nc(NC3CCCNC3)nc3CCN(CCc23)c2ncccc2C(F)(F)F)cc1 InChI=1S/C26H27F6N7/c27-25(28,29)16-5-7-17(8-6-16)35-22-19-9-13-39(23-20(26(30,31)32)4-2-12-34-23)14-10-21(19)37-24(38-22)36-18-3-1-11-33-15-18/h2,4-8,12,18,33H,1,3,9-11,13-15H2,(H2,35,36,37,38) VZAFKJMMFIFKPS-UHFFFAOYSA-N 50332862 N2-(piperidin-3-yl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630626 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus >5000 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332862 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332862&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53320484 125082964 CHEMBL1630626 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613203 CN1CCCC(C1)Nc1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C27H29F6N7/c1-39-13-3-4-19(16-39)36-25-37-22-11-15-40(24-21(27(31,32)33)5-2-12-34-24)14-10-20(22)23(38-25)35-18-8-6-17(7-9-18)26(28,29)30/h2,5-9,12,19H,3-4,10-11,13-16H2,1H3,(H2,35,36,37,38) UKGUYMZTTOHLED-UHFFFAOYSA-N 50332863 N2-(1-methylpiperidin-3-yl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630627 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus >5000 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332863 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332863&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53325772 125082965 CHEMBL1630627 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613204 CN(C1CCCN(C1)C(=O)OC(C)(C)C)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C32H37F6N7O2/c1-30(2,3)47-29(46)45-16-6-7-22(19-45)43(4)28-41-25-14-18-44(27-24(32(36,37)38)8-5-15-39-27)17-13-23(25)26(42-28)40-21-11-9-20(10-12-21)31(33,34)35/h5,8-12,15,22H,6-7,13-14,16-19H2,1-4H3,(H,40,41,42) UYKWYCSLAOFZHJ-UHFFFAOYSA-N 50332864 tert-butyl 3-(methyl(4-(4-(trifluoromethyl)phenylamino)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-2-yl)amino)piperidine-1-carboxylate::CHEMBL1630628 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 97 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332864 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332864&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53321783 125082966 CHEMBL1630628 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613205 CN(C1CCCNC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C27H29F6N7/c1-39(19-4-2-12-34-16-19)25-37-22-11-15-40(24-21(27(31,32)33)5-3-13-35-24)14-10-20(22)23(38-25)36-18-8-6-17(7-9-18)26(28,29)30/h3,5-9,13,19,34H,2,4,10-12,14-16H2,1H3,(H,36,37,38) UNQRZPZKFDHQJJ-UHFFFAOYSA-N 50332865 N2-methyl-N2-(piperidin-3-yl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630629 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 1540 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332865 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332865&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53316531 125082967 CHEMBL1630629 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613206 CN(C1CCCN(C)C1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C28H31F6N7/c1-39-14-4-5-20(17-39)40(2)26-37-23-12-16-41(25-22(28(32,33)34)6-3-13-35-25)15-11-21(23)24(38-26)36-19-9-7-18(8-10-19)27(29,30)31/h3,6-10,13,20H,4-5,11-12,14-17H2,1-2H3,(H,36,37,38) GBYAZONQWPEDEC-UHFFFAOYSA-N 50332866 N2-methyl-N2-(1-methylpiperidin-3-yl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630630 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus >5000 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332866 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332866&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53320373 125082968 CHEMBL1630630 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613207 CC(C)(C)OC(=O)N1CCCCC1CNc1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C32H37F6N7O2/c1-30(2,3)47-29(46)45-16-5-4-7-22(45)19-40-28-42-25-14-18-44(27-24(32(36,37)38)8-6-15-39-27)17-13-23(25)26(43-28)41-21-11-9-20(10-12-21)31(33,34)35/h6,8-12,15,22H,4-5,7,13-14,16-19H2,1-3H3,(H2,40,41,42,43) QBAAPNYTIXKOSR-UHFFFAOYSA-N 50332867 tert-butyl 2-((4-(4-(trifluoromethyl)phenylamino)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-2-ylamino)methyl)piperidine-1-carboxylate::CHEMBL1630631 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 230 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332867 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332867&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53320485 125082969 CHEMBL1630631 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613208 FC(F)(F)c1ccc(Nc2nc(NCC3CCCCN3)nc3CCN(CCc23)c2ncccc2C(F)(F)F)cc1 InChI=1S/C27H29F6N7/c28-26(29,30)17-6-8-18(9-7-17)37-23-20-10-14-40(24-21(27(31,32)33)5-3-13-35-24)15-11-22(20)38-25(39-23)36-16-19-4-1-2-12-34-19/h3,5-9,13,19,34H,1-2,4,10-12,14-16H2,(H2,36,37,38,39) VZEJNYBCKKADCX-UHFFFAOYSA-N 50332868 N2-(piperidin-2-ylmethyl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630632 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus >5000 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332868 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332868&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53324459 125082970 CHEMBL1630632 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613209 CN1CCCCC1CNc1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C28H31F6N7/c1-40-14-3-2-5-20(40)17-36-26-38-23-12-16-41(25-22(28(32,33)34)6-4-13-35-25)15-11-21(23)24(39-26)37-19-9-7-18(8-10-19)27(29,30)31/h4,6-10,13,20H,2-3,5,11-12,14-17H2,1H3,(H2,36,37,38,39) JZNBBUHXLHNYJX-UHFFFAOYSA-N 50332869 N2-((1-methylpiperidin-2-yl)methyl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1630633 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 2277 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332869 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332869&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53317849 125082971 CHEMBL1630633 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613210 CN(CC1CCCCN1C)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C29H33F6N7/c1-40-15-4-3-6-21(40)18-41(2)27-38-24-13-17-42(26-23(29(33,34)35)7-5-14-36-26)16-12-22(24)25(39-27)37-20-10-8-19(9-11-20)28(30,31)32/h5,7-11,14,21H,3-4,6,12-13,15-18H2,1-2H3,(H,37,38,39) JYLAXWCUPMUZAQ-UHFFFAOYSA-N 50332870 N2-methyl-N2-((1-methylpiperidin-2-yl)methyl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1631258 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus >5000 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332870 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332870&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53319909 125082972 CHEMBL1631258 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613211 FC(F)(F)c1ccc(Nc2nc(NCc3ccccn3)nc3CCN(CCc23)c2ncccc2C(F)(F)F)cc1 InChI=1S/C27H23F6N7/c28-26(29,30)17-6-8-18(9-7-17)37-23-20-10-14-40(24-21(27(31,32)33)5-3-13-35-24)15-11-22(20)38-25(39-23)36-16-19-4-1-2-12-34-19/h1-9,12-13H,10-11,14-16H2,(H2,36,37,38,39) HULIPYRTZHBHFC-UHFFFAOYSA-N 50332871 N2-(pyridin-2-ylmethyl)-N4-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepine-2,4-diamine::CHEMBL1631259 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 1342 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332871 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332871&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 53326824 125082973 CHEMBL1631259 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613213 CC(C)CN1CCN(CC1)c1nc2CCN(CCc2c(Nc2ccc(cc2)C(F)(F)F)n1)c1ncccc1C(F)(F)F InChI=1S/C29H33F6N7/c1-19(2)18-40-14-16-42(17-15-40)27-38-24-10-13-41(26-23(29(33,34)35)4-3-11-36-26)12-9-22(24)25(39-27)37-21-7-5-20(6-8-21)28(30,31)32/h3-8,11,19H,9-10,12-18H2,1-2H3,(H,37,38,39) IBGHJRNYLZKHRY-UHFFFAOYSA-N 50332846 2-(4-isobutylpiperazin-1-yl)-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1630299 Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 63 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50332846 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50332846&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 49870854 125082948 CHEMBL1630299 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57 50613216 FC(F)(F)c1ccc(Nc2nc(nc3CCN(CCc23)c2ncccc2C(F)(F)F)N2CCOCC2)cc1 InChI=1S/C25H24F6N6O/c26-24(27,28)16-3-5-17(6-4-16)33-21-18-7-10-36(22-19(25(29,30)31)2-1-9-32-22)11-8-20(18)34-23(35-21)37-12-14-38-15-13-37/h1-6,9H,7-8,10-15H2,(H,33,34,35) LKHROBPDTDXUDN-UHFFFAOYSA-N 50331116 2-morpholino-N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)-6,7,8,9-tetrahydro-5H-pyrimido[5,4-d]azepin-4-amine::CHEMBL1289607::US9422293, 40 and 40A::US9738649, Example 40A Transient receptor potential cation channel subfamily V member 1 Rattus norvegicus 19 ChEMBL 10.1016/j.bmcl.2010.09.006 10.7270/Q26Q1XH0 20932750 Lebsack, AD; Rech, JC; Branstetter, BJ; Hawryluk, NA; Merit, JE; Allison, B; Rynberg, R; Buma, J; Rizzolio, M; Swanson, N; Ao, H; Maher, MP; Herrmann, M; Freedman, J; Scott, BP; Luo, L; Bhattacharya, A; Wang, Q; Chaplan, SR; Wickenden, AD; Breitenbucher, JG 11/8/2010 8/20/2011 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50331116 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2071&target=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50331116&enzyme=Transient+receptor+potential+cation+channel+subfamily+V+member+1&column=ki&startPg=0&Increment=50&submit=Search 24783403 123110231 CHEMBL1289607 1 MEQRASLDSEESESPPQENSCLDPPDRDPNCKPPPVKPHIFTTRSRTRLFGKGDSEEASPLDCPYEEGGLASCPIITVSSVLTIQRPGDGPASVRPSSQDSVSAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLNRLLQDKWDRFVKRIFYFNFFVYCLYMIIFTAAAYYRPVEGLPPYKLKNTVGDYFRVTGEILSVSGGVYFFFRGIQYFLQRRPSLKSLFVDSYSEILFFVQSLFMLVSVVLYFSQRKEYVASMVFSLAMGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYLVFLFGFSTAVVTLIEDGKNNSLPMESTPHKCRGSACKPGNSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVFIILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKAFRSGKLLQVGFTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRSGRVSGRNWKNFALVPLLRDASTRDRHATQQEEVQLKHYTGSLKPEDAEVFKDSMVPGEK 9W4T,9W4M,9OGK,7MZ5,7L2O,7L2N,7L2M,7L2L,7L2K,7L2J,7L2I,7L2H,7RQZ,7RQY,7RQX,7RQW,7RQV,7RQU,7LPE,7LPD,7LPC,7LPB,7LPA,7LP9,9ISG,9W4N,8U3L,8U3C,8U30,8T10,8T0Y,8T0E,8T0C,8T3M,8T3L,7MZE,7MZD,7MZC,7MZB,7MZA,7MZ9,7MZ7,7MZ6,7L2X,7L2W,7L2V,7L2U,7L2T,7L2S,7L2R,7L2P,8U4D,8U43,8U3A,8U2Z,5IS0,5IRZ,5IRX,3J5R,3J5Q,3J5P,8U3J Transient receptor potential cation channel subfamily V member 1 TRPV1_RAT O35433 Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57